acivicin and Encephalopathy, Toxic

acivicin has been researched along with Encephalopathy, Toxic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dryhurst, G; Foster, SB; Miller, KE; Tang, H1
Aguirre, N; de la Torre, R; Goñi-Allo, B; Hervias, I; Lasheras, B; Mathúna, BO; Puerta, E1
Bai, F; Jones, DC; Lau, SS; Monks, TJ1

Other Studies

3 other study(ies) available for acivicin and Encephalopathy, Toxic

ArticleYear
Increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [MPP(+)] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione.
    Neurotoxicity research, 2005, Volume: 7, Issue:4

    Topics: 1-Methyl-4-phenylpyridinium; Amino Acids; Animals; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Electrochemistry; Enzyme Inhibitors; Extracellular Space; gamma-Glutamyltransferase; Glutamic Acid; Glutathione; Immunohistochemistry; Isoxazoles; Male; Microdialysis; Neostriatum; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Serotonin

2005
On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats.
    Neuropharmacology, 2008, Volume: 54, Issue:5

    Topics: Analysis of Variance; Animals; Antimetabolites; Area Under Curve; Body Temperature; Brain; Catechols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Hydroxyindoleacetic Acid; Isoxazoles; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Nitriles; Protein Binding; Rats; Rats, Wistar; Serotonin; Time Factors; Tyrosine

2008
Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase.
    Chemical research in toxicology, 2001, Volume: 14, Issue:7

    Topics: 3,4-Methylenedioxyamphetamine; Administration, Cutaneous; Animals; Brain; Endothelium; Enzyme Inhibitors; gamma-Glutamyltransferase; Humans; Isoxazoles; Male; Models, Molecular; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents

2001